Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents

Annals of the Rheumatic Diseases
Eirik Hornes HalvorsenOyvind Molberg

Abstract

Peptidylarginine deiminase 4 (PAD4) may generate epitopes targeted by anticitrullinated protein antibodies in rheumatoid arthritis (RA). A subset of patients with RA has serum autoantibodies to human recombinant PAD4 (hPAD4). Here, we assessed whether anti-hPAD4 status in RA predicted disease outcome after antitumour necrosis factor (anti-TNF)-alpha therapy. We analysed RA sera obtained at baseline (n = 40) and after 1 year on anti-TNF-alpha therapy (n = 33) for anti-hPAD4 IgG. Association analyses between baseline anti-hPAD status and disease progression were performed. We found that 17 of 40 patients (42.5%) were serum anti-hPAD4 positive at baseline, and the anti-hPAD4 IgG levels were stable over 1 year on anti-TNF-alpha therapy. At baseline, there were indications that anti-hPAD4 positive patients had more severe disease than the negative patients. After 1 year on anti-TNF-alpha therapy, the anti-hPAD4 positive patients displayed a persistently elevated disease activity score using 28 joint counts score and increased progression in the van der Heijde-modified Sharp erosion score. Accordingly, more anti-hPAD4 positive than negative patients presented an increase in van der Heijde-modified Sharp erosion scores >0 over 1 year....Continue Reading

Citations

Jun 8, 2011·Nature Reviews. Rheumatology·Walther J van VenrooijGer J M Pruijn
Feb 4, 2010·Rheumatology·Ian N BruceDavid Isenberg
May 4, 2012·Arthritis Research & Therapy·Amanda S RohrbachKerri A Mowen
Apr 26, 2014·Seminars in Immunopathology·Marieke BaxRené E M Toes
Feb 26, 2016·Annual Review of Immunology·Antony Rosen, Livia Casciola-Rosen
May 25, 2010·Arthritis and Rheumatism·Jason R KolfenbachV Michael Holers
Jul 8, 2020·Journal of Clinical Medicine·Bogdan KolarzMaria Majdan
Apr 29, 2020·Nature Reviews. Rheumatology·Ashley M CurranErika Darrah
Jul 15, 2020·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Bogdan KolarzRafal Podgorski
Feb 26, 2021·Therapeutic Advances in Musculoskeletal Disease·Bogdan KolarzMaria Majdan

❮ Previous
Next ❯